Showing results (1341-1350 of 1,380) with videos related to

Sort By:
Pageof 138
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 AntagonistChu-Biao Xue, Hao Feng, Ganfeng Cao, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 AntagonistChu-Biao Xue, Anlai Wang, Qi Han, et al.
ACS Medicinal Chemistry Letters|November 22, 2019
INCB050465 (Parsaclisib), a Novel Next-Generation Inhibitor of Phosphoinositide 3-Kinase Delta (PI3Kδ)Eddy W Yue, Yun-Long Li, Brent Douty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2014
Mutational landscape of aggressive cutaneous squamous cell carcinomaCurtis R Pickering, Jane H Zhou, J Jack Lee, et al.
JCO Precision Oncology|June 29, 2023
31-Gene Expression Profile Testing in Cutaneous Melanoma and Survival Outcomes in a Population-Based Analysis: A SEER CollaborationChristine N Bailey, Brian J Martin, Valentina I Petkov, et al.
Oncotarget|January 5, 2017
Non-malignant respiratory epithelial cells preferentially proliferate from resected non-small cell lung cancer specimens cultured under conditionally reprogrammed conditionsBoning Gao, Chunxian Huang, Kemp Kernstine, et al.
Blood|September 10, 2024
Selective targeting of mutated calreticulin by the monoclonal antibody INCA033989 inhibits oncogenic function of MPNEdimara S Reis, Rebecca Buonpane, Hamza Celik, et al.
The Journal of Infectious Diseases|May 23, 2024
Fecal microbiota and volatile metabolome pattern alterations precede late-onset meningitis in preterm neonatesNina M Frerichs, Nancy Deianova, Sofia El Manouni El Hassani, et al.
Journal of Medicinal Chemistry|July 27, 2001
Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivoC B Xue, M E Voss, D J Nelson, et al.
Cancer Biology & Therapy|April 22, 2006
Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cellsPhillip C C Liu, Xiangdong Liu, Yanlong Li, et al.
Pageof 138